A passionate leader with a proven record of building high-performance teams, Greg has played a key role in transforming Myonex from a comparator sourcing supplier to an integrated clinical trial supply and commercial packaging service provider—most notably by driving three strategic acquisitions in Germany, France, and the United States and by helping develop a strategic plan to drive organizational performance. Prior to joining Myonex as Chief Financial Officer in 2019, Greg worked with QPS Holdings LLC, a PE-backed clinical research organization, as their Chief Financial Officer, where he led the integration and transformation of the business after a series of global acquisitions. Greg also has held financial leadership roles at PE-backed companies SDI, Inc. and SDI Health, LLC. Earlier in his career, Greg served as a consultant for firms such as Arthur Andersen, PwC, and KPMG. A graduate of Boston College, he holds a B.S. in both Accounting and Finance, and is a CPA.